10328395

Source:http://linkedlifedata.com/resource/pubmed/id/10328395

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0000880, umls-concept:C0008976, umls-concept:C0027603, umls-concept:C0072160, umls-concept:C0087111, umls-concept:C0205195, umls-concept:C0591200, umls-concept:C1257890, umls-concept:C1274040, umls-concept:C2603343
pubmed:issue	5
pubmed:dateCreated	1999-5-21
pubmed:abstractText	To characterize patients with Acanthamoeba keratitis and to evaluate the safety and efficacy of propamidine isethionate 0.1% ophthalmic solution (Brolene) when administered concomitantly with neomycin-polymyxin B-gramicidin ophthalmic solution (Neotricin) in the treatment of Acanthamoeba keratitis.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/EYO9756
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7802443
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antiprotozoal Agents, http://linkedlifedata.com/resource/pubmed/chemical/Benzamidines, http://linkedlifedata.com/resource/pubmed/chemical/Neomycin, http://linkedlifedata.com/resource/pubmed/chemical/Ophthalmic Solutions, http://linkedlifedata.com/resource/pubmed/chemical/propamidine isethionate
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	0161-6420
pubmed:author	pubmed-author:HargraveS LSL, pubmed-author:HusseiniZZ, pubmed-author:McCulleyJ PJP
pubmed:issnType	Print
pubmed:volume	106
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	952-7
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:10328395-Acanthamoeba Keratitis, pubmed-meshheading:10328395-Adolescent, pubmed-meshheading:10328395-Adult, pubmed-meshheading:10328395-Aged, pubmed-meshheading:10328395-Anti-Bacterial Agents, pubmed-meshheading:10328395-Antiprotozoal Agents, pubmed-meshheading:10328395-Benzamidines, pubmed-meshheading:10328395-Contact Lenses, pubmed-meshheading:10328395-Drug Therapy, Combination, pubmed-meshheading:10328395-Eye Enucleation, pubmed-meshheading:10328395-Female, pubmed-meshheading:10328395-Humans, pubmed-meshheading:10328395-Keratoplasty, Penetrating, pubmed-meshheading:10328395-Male, pubmed-meshheading:10328395-Middle Aged, pubmed-meshheading:10328395-Neomycin, pubmed-meshheading:10328395-Ophthalmic Solutions, pubmed-meshheading:10328395-Prospective Studies, pubmed-meshheading:10328395-Safety, pubmed-meshheading:10328395-Treatment Outcome
pubmed:year	1999
pubmed:articleTitle	Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene Study Group.
pubmed:affiliation	Department of Ophthalmology, The University of Texas Southwestern Medical Center at Dallas, 75235-9057, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Controlled Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study